• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Enorama Pharma

0.30 SEK

0.00 %

Less than 1K followers

ERMA

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
0.00 %
-17.32 %
-29.52 %
-85.09 %
-84.50 %
-87.67 %
-90.65 %
-98.04 %
-95.35 %

Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are sold mainly through retailers who sell the product under their own brand. The largest market is found in the Nordic region, but with a share of sales exported globally. Enorama Pharma was founded in 2006 and the headquarters are located in Malmö.

Read more
Market cap
22.08M SEK
Turnover
474.36 SEK
Revenue
2.74M
EBIT %
-2,293.17 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
19.8
2026

Interim report Q2'26

18.11
2026

Interim report Q3'26

17.2
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release16.06.2026, 16.55

ENORAMA PHARMA: BULLETIN FROM THE ANNUAL GENERAL MEETING OF ENORAMA PHARMA AB (PUBL)

Enorama Pharma
Regulatory press release13.05.2026, 08.30

Notice of annual general meeting of Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release07.04.2026, 15.00

Enorama Pharma: PRESS RELEASE FROM THE EXTRAORDINARY GENERAL MEETING, AND FIRST CONTROL MEETING, IN ENORAMA PHARMA AB (PUBL)

Enorama Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release17.03.2026, 15.00

Notice of extraordinary general meeting and first control meeting in Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release03.03.2026, 10.30

Enorama Pharma AB (publ) resolves to postpone the planned extraordinary general meeting

Enorama Pharma
Regulatory press release19.02.2026, 15.00

Notice of extraordinary general meeting in Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release13.02.2026, 11.50

Enorama Pharma AB (publ) postpones publication of its 2025 year-end report

Enorama Pharma
Regulatory press release13.02.2026, 11.45

Enorama Pharma AB (publ) decides to prepare a balance sheet for liquidation purposes

Enorama Pharma
Regulatory press release02.12.2025, 14.30

Enorama Pharma: BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN ENORAMA PHARMA AB (PUBL)

Enorama Pharma
Regulatory press release12.11.2025, 16.00

Notice of extraordinary general meeting in Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release25.09.2024, 12.00

Enorama Pharma AB (publ) Explores Divestment of Nicotine Replacement Therapy Chewing Gum Business

Enorama Pharma